Evidence map›Paper›PMID 25209945›Full record

ArticleEuropean journal of immunology2014

T/B-cell interactions are more transient in response to weak stimuli in SLE-prone mice.

Parisa Sinai, Igor M Dozmorov, Ran Song, Pamela L Schwartzberg, Edward K Wakeland, Christoph Wülfing

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. [Research progress on the application of telitacicept in rheumatism and autoimmune diseases].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Review
  3. Aberrant B-Cell Activation in Systemic Lupus Erythematosus.Kidney diseases (Basel, Switzerland) · 2022
    Review
  4. Antigen-specific depletion of CD4Science immunology · 2022
    Article
  5. Article
  6. B Cell Aberrance in Lupus: the Ringleader and the Solution.Clinical reviews in allergy & immunology · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. B cell contribution of the CD4Autoimmunity · 2017
    Review
  14. Systems Imaging of the Immune Synapse.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  15. Review
  16. B cell-intrinsic CD84 and Ly108 maintain germinal center B cell tolerance.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  17. Defects in Germinal Center Selection in SLE.Frontiers in immunology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Parisa SinaiSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, UK; Department of Immunology, UT Southwestern Medical Center, Dallas, TX, USA.
Igor M Dozmorov
Ran Song
Pamela L Schwartzberg
Edward K Wakeland
Christoph Wülfing
The University of Texas Southwestern Medical Center · USNational Human Genome Research Institute · USSouthwestern Medical CenterSouthwestern Medical Center · US

Funding

Genetic and Biochemical Approaches to Tyrosine Kinase FunctionZIAHG000123 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SCHWARTZBERG, PAMELA · 2009 to 2018
$20.8M
Regulation of the T Cell Cytoskeleton by CostimulationR01CA090436 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WUELFING, CHRISTOPH · 2003 to 2009
$1.4M
NCI NIH HHS CA90436NCI NIH HHS R01 CA090436
6 · The paper itself

Abstract

Changes in immune function during the course of systemic lupus erythematosus (SLE) are well characterized. Class-switched antinuclear antibodies are the hallmark of SLE, and T/B-cell interactions are thus critical. However, changes in immune function contributing to disease susceptibility are unknown. Here, we have analyzed primary T and B cells from a mouse model of SLE prior to the onset of disease. To allow cognate T-cell activation with low affinity, we have developed a lower potency peptide ligand for the OTII TCR. T- and B-cell couples formed less frequently and retained their polarity less efficiently preferentially in response to low-affinity stimulation in SLE-prone mice. This matched decreased recruitment of actin and Vav1 and an enhanced PKCΘ recruitment to the cellular interface in T cells. The induction of the GC B-cell marker GL7 was increased in T/B cell couples from SLE-prone mice when the T-cell numbers were limited. However, the overall gene expression changes were marginal. Taken together, the enhanced cell-couple transience may allow a more efficient sampling of a large number of T/B cell couples, preferentially in response to limiting stimuli, therefore enhancing the immune reactivity in the development of SLE.

Indexed as

Lymphocyte ActivationAnimalsB-LymphocytesCell CommunicationFemaleGene Expression RegulationGerminal CenterLupus Erythematosus, SystemicMiceProtein Kinase C-epsilonProto-Oncogene Proteins c-vavT-LymphocytesPrkce protein, mouseProtein Kinase C-epsilonProto-Oncogene Proteins c-vavVav1 protein, mouseActinImagingImmunological synapseProtein kinase CSystemic lupus erythematosus

Identifiers

PMID25209945
PMCPMC4261040
OpenAlexW1917953725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.